Previous 10 | Next 10 |
home / stock / asapf / asapf news
CARLSBAD, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants, today announced the FDA clearance of a new Lumbar Spinal Stenosis Indication f...
CARLSBAD, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of United States Patent No:...
Aurora Spine (OTCQB:ASAPF) said the U.S. Food and Drug Administration granted 510(k) clearance to its Dexa Solo-L spinal fusion system. The company said in a June 6 press release that the system, which is part of the DEXA Technology platform, is a standalone device for anterior and lateral lu...
CARLSBAD, Calif, June 06, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it had received FDA 510(k) clea...
Aurora Spine has three products, DEXA, SILO, and ZIP that have been met with early strong market interest evidenced by sequential quarterly revenue growth exceeding 20% over the last year. DEXA is the first commercially available technology that provides customized devices matching an...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovati...
CARLSBAD, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue...
Aurora Spine Corporation press release (OTCQB:ASAPF): Q4 GAAP EPS of -$0.01. Revenue of $2.96M (+21.3% Y/Y). EBITDAC was -$0.57M for the fourth quarter of 2021, compared to -$0.27M in the fourth quarter of 2020. Gross margin on total revenues were 46.0% for the fourth quarter of 2021, c...
Aurora Spine Corporation (ASAPF) Q4 2021 Earnings Conference Call May 02, 2022 11:00 AM ET Company Participants Adam Lowensteiner - Investor Relations, Lytham Partners Trent Northcutt - President & Chief Executive Officer Chad Clouse - Chief Financial Officer Conference Call Participants ...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong r evenue g rowth of 22 % in Q4 and e xpects sequential increase in revenues for Q1 2022 - ...
News, Short Squeeze, Breakout and More Instantly...
CARLSBAD, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will be partici...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine tech...
CARLSBAD, Calif. , May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has schedu...